These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 33363047)

  • 21. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.
    Gregory CJ; Llata E; Stine N; Gould C; Santiago LM; Vazquez GJ; Robledo IE; Srinivasan A; Goering RV; Tomashek KM
    Infect Control Hosp Epidemiol; 2010 May; 31(5):476-84. PubMed ID: 20334553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity of eugenol against carbapenem-resistant Klebsiella pneumoniae and its effect on biofilms.
    Qian W; Sun Z; Wang T; Yang M; Liu M; Zhang J; Li Y
    Microb Pathog; 2020 Feb; 139():103924. PubMed ID: 31837416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
    Borer A; Saidel-Odes L; Eskira S; Nativ R; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
    Su CF; Chuang C; Lin YT; Chan YJ; Lin JC; Lu PL; Huang CT; Wang JT; Chuang YC; Siu LK; Fung CP
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):651-659. PubMed ID: 29238934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
    Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
    Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
    Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
    BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissemination of Klebsiella pneumoniae ST11 isolates with carbapenem resistance in integrated and emergency intensive care units in a Chinese tertiary hospital.
    Yu F; Hu L; Zhong Q; Hang Y; Liu Y; Hu X; Ding H; Chen Y; Xu X; Fang X; Yu F
    J Med Microbiol; 2019 Jun; 68(6):882-889. PubMed ID: 31050634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study.
    Gómez Rueda V; Zuleta Tobón JJ
    Colomb Med (Cali); 2014; 45(2):54-60. PubMed ID: 25100889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital.
    Stillwell T; Green M; Barbadora K; Ferrelli JG; Roberts TL; Weissman SJ; Nowalk A
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):330-8. PubMed ID: 26582872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.
    Schwaber MJ; Klarfeld-Lidji S; Navon-Venezia S; Schwartz D; Leavitt A; Carmeli Y
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1028-33. PubMed ID: 18086836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance.
    Yu X; Zhang W; Zhao Z; Ye C; Zhou S; Wu S; Han L; Han Z; Ye H
    BMC Genomics; 2019 Nov; 20(1):822. PubMed ID: 31699025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of siderophore virulence genes entB and ybtS on the virulence of Carbapenem-resistant Klebsiella pneumoniae.
    Han R; Niu M; Liu S; Mao J; Yu Y; Du Y
    Microb Pathog; 2022 Oct; 171():105746. PubMed ID: 36064103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals.
    Han JH; Goldstein EJ; Wise J; Bilker WB; Tolomeo P; Lautenbach E
    Clin Infect Dis; 2017 Apr; 64(7):839-844. PubMed ID: 28013258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure.
    Chia JH; Su LH; Lee MH; Kuo AJ; Shih NY; Siu LK; Wu TL
    Microb Drug Resist; 2010 Dec; 16(4):317-25. PubMed ID: 20524901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
    Kofteridis DP; Valachis A; Dimopoulou D; Maraki S; Christidou A; Mantadakis E; Samonis G
    J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China.
    Zhang Y; Zeng J; Liu W; Zhao F; Hu Z; Zhao C; Wang Q; Wang X; Chen H; Li H; Zhang F; Li S; Cao B; Wang H
    J Infect; 2015 Nov; 71(5):553-60. PubMed ID: 26304687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk factors for nosocomial infection of carbapenem-resistant
    Dai L; Li F; Jiang HC; Jiang L
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Sept 15; 24(9):1008-1013. PubMed ID: 36111719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
    Mills JP; Talati NJ; Alby K; Han JH
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):55-60. PubMed ID: 26455382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.